Merck struts drug label redesign; Hong Kong orders GSK drug recall;

> The FDA has approved Merck's redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation. FDA release

> GSK will recall a pediatric antibiotic per Hong Kong mandate after officials found two times the limit of a plasticizer in the product. Story

> Drugmakers are urging India's prime minister to postpone implementation of a barcoding mandate to protect India from losing business to China. Item

> U.S. flu vaccine coverage reached all-time high in the 2010-2011 season. Story

> Egg-based vaccine production will likely be the main source for years to come. News

> GlaxoSmithKline will invest more than $30 million in pharmaceutical innovation and advanced manufacturing research in Mississauga, Ontario. Release

> Watson Pharmaceuticals has formally dedicated its global corporate headquarters in Parsippany, NJ. Item

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.